SAR-125844

SynDRA canonical compound SYN0039884 — structure-anchored drug synonym record

Clinical phase	Phase 2
Primary target(s)	MET
Mechanism of action	c-met inhibitor
Indication	gastric adenocarcinoma
Disease area	oncology

All known targets

MET

Mechanisms of action (all sources)

MET INHIBITOR
Hepatocyte growth factor receptor inhibitor

Cross-references

PubChem CID: 25182860
ChEMBL: CHEMBL4461070
DrugBank: DB15382
PDB: 63K
TTD: D07ARN

Synonyms

SAR 125844
SAR125844
Met inhibitor (iv, cancer), sanofi-aventis
XH93U6NIJE
RefChem:181305
DTXCID001516349
MET Tyrosine Kinase Inhibitor SAR125844
SAR125884
UNII-XH93U6NIJE
orb1689883
SCHEMBL2801192
C25H23FN8O2S2
ODIUNTQOXRXOIV-UHFFFAOYSA-N
EX-A2198
RUB74346
BDBM50532757
NSC771652
s7564
AKOS032954063
EBC-221139
NSC-771652
SAR125844?
SB16715
AC-35976
BS-14459
DA-57657
HY-16446
CS-0006341
T5467
N17079

Look up SAR-125844 in the interactive SynDRA portal →